Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

G&L Scientific PeopleG&L Scientific People
VS
MACLEODS PHARMACEUTICALS LTD.MACLEODS PHARMACEUTICALS LTD.
G&L Scientific People

G&L Scientific People

N/A

Last Update: 13/02/2026

View Profile
Between 750 and 799
https://www.gandlscientific.com/contact/join-our-team/
753/1000Fair

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
MACLEODS PHARMACEUTICALS LTD.

MACLEODS PHARMACEUTICALS LTD.

304, Atlanta Arcade Marol Church Road, Mumbai, 400059, IN

Last Update: 30/03/2026

View Profile
Between 750 and 799
https://www.macleodspharma.com
775/1000Fair

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermato...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:11,821
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
G&L Scientific People

G&L Scientific People

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MACLEODS PHARMACEUTICALS LTD.

MACLEODS PHARMACEUTICALS LTD.

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for G&L Scientific People in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2026.

Incidents

Incident History - G&L Scientific People (X = Date, Y = Severity)

G&L Scientific People cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MACLEODS PHARMACEUTICALS LTD. (X = Date, Y = Severity)

MACLEODS PHARMACEUTICALS LTD. cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
G&L Scientific People

G&L Scientific People

Incidents
No explicit notable incidents reported.
MACLEODS PHARMACEUTICALS LTD.

MACLEODS PHARMACEUTICALS LTD.

Incidents
No explicit notable incidents reported.

FAQ

Between G&L Scientific People company and MACLEODS PHARMACEUTICALS LTD. company, which one has the best AI Cybersecurity Score ?
Between G&L Scientific People company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced more cyber incidents in the past ?
Between G&L Scientific People company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced more cyber incidents this year ?
Between G&L Scientific People company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced at least one ransomware attack ?
Between G&L Scientific People company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced at least one data breach ?
Between G&L Scientific People company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced at least one targeted cyberattack ?
Between G&L Scientific People company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced at least one vulnerability ?
Between G&L Scientific People company and MACLEODS PHARMACEUTICALS LTD. company, which one holds the most compliance certifications ?
Between G&L Scientific People company and MACLEODS PHARMACEUTICALS LTD. company, which one holds the fewest compliance certifications ?
Between G&L Scientific People company and MACLEODS PHARMACEUTICALS LTD. company, which one has the most subsidiaries ?
Between G&L Scientific People company and MACLEODS PHARMACEUTICALS LTD. company, which one has the largest number of employees ?
Between G&L Scientific People and MACLEODS PHARMACEUTICALS LTD., which company holds both SOC 2 Type 1 certifications ?
Between G&L Scientific People and MACLEODS PHARMACEUTICALS LTD., which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - G&L Scientific People or MACLEODS PHARMACEUTICALS LTD. ?
Which company is PCI DSS compliant - G&L Scientific People or MACLEODS PHARMACEUTICALS LTD. ?
Between G&L Scientific People and MACLEODS PHARMACEUTICALS LTD., which company complies with HIPAA regulations for healthcare data ?
Between G&L Scientific People and MACLEODS PHARMACEUTICALS LTD., which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60455
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60439
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60373
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60372
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
REFERENCES